AVP and heart disorder: Therefore, regardless of stimuli being tonicity related or uncoupled to osmolality as in CHF states, copeptin might be a clinically applicable biomarker in dogs with heart disease that could be useful in identifying dogs with excessive ADH secretion that could benefit from additional therapy aimed at decreasing free water retention or antagonizing the underlying RAAS stimulation.